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Adult T  cell leukemia (ATL), endemic in Japan and other countries, is thought 
to be caused by type I human T  cell leukemia/lymphoma (lymphotrophic) virus 
(HTLV-I)  (1-5).  In the majority of instances, both the leukemic cells and the 
established T  cell lines have a  surface phenotype of helper T  cells, and express 
interleukin 2 (IL-2) receptors (2, 6-9).  The abnormal IL-2 receptor expression 
on these cell lines is due to the constitutive transcription of the IL-2 receptor 
gene  (10,  1 1).  It is important  to examine the  clonal origin of the  established 
ATL cell lines, particularly because  leukemic cells of acute ATL cases do not 
proliferate in response to IL-2, despite the expression of the IL-2 receptor (12). 
A  mature T  cell  has unique rearrangements of cellular genes encoding the T 
cell antigen receptor (13,  14). Since ATL is a  leukemia of mature peripheral T 
cells (1,  2),  the rearrangement profile of the T  cell receptor gene is a  suitable 
genetic  marker  for  tracing  the  clonal  origin  of ATL  cells  and  the  cell  lines 
established from the patients. Using the genomic fragment encoding the/3 chain 
of the  human  T  cell  receptor  (T¢)  as  probe,  we analyzed the  rearrangement 
profiles of Te gene in leukemic cells and cell lines from various ATL cases. Based 
on the findings, we discuss the origin of HTLV-I  + T  cell lines derived from ATL 
patients and the role of I L-2/I L-2-receptor system (15, 16) on the leukemogenesis 
in ATL. 
Materials and Methods 
Cell Culture.  Cells were cultured in RPMI-1640 medium supplemented with 10-20% 
of fetal calf serum (FCS) (Rehatuin, Armour Pharmaceutical Co. Ltd., Kankakee, IL) IL- 
2-dependent T  cells were cultured in petri dishes with crude or recombinant IL-2 (see 
below) in humidified atmosphere of 5% COs in air at 37°C. 
lnterleukin 2.  To obtain crude IL-2 2 ×  I0  ° spleen cells/ml were cultured for 48-72 
h in the presence of 0.1% phytohemagglutinin-P (PHA-P) (Difco Laboratories, Detroit, 
MI), 10  -6 M indomethacin (Sigma Chemical Co., St. Louis, MO), and 2% FCS. Recom- 
binant IL-2 produced by yeast or by E.  coli was kindly provided by Suntry Co., Osaka, 
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Japan,  and  Takeda Pharmaceutical Co.,  Osaka,  respectively. IL-2 activity was  titrated 
using the mouse IL-2-dependent cytotoxic T  lymphocyte (CTLL-2) cell line (15). 
Southern  Blot Hybridization.  Human T  cell receptor/3 chain gene was isolated from 
normal  human  placenta  DNA  (17) by crosshybridization with  mouse T o chain cDNA 
provided by M.  Davis (14).  A  2.6 kilobase (kb) Hind |II fragment, containing constant 
region of the human/3 chain, was used as the To probe. For the detection of the provirus 
of HTLV-I, the long terminal repeats (LTR) (Sma I-Sac I, 456 base pairs [bp]) (18) was 
used as the probe. High-molecular weight DNA extraction from the cells, digestion with 
appropriate restriction enzymes (Eco RI or Barn  HI), electrophoresis in 0.6%  agarose, 
blotting to nitrocellulose filter, and hybridization (15  h,  65°C)  with  32p-labeled,  nick- 
translated  probes  were  carried out  as  described (19).  Filters  were  washed  with  0.3× 
standard sodium citrate (SSC) with 0.1% sodium dodecyl sulfate (SDS) (Ta probe) or 0.1 × 
SSC with 0.1% SDS (HTLV probe) at 65°C (19). 
T Cell Lines Derived from ATL Patients.  Leukemic cells separated from ATL patients 
were cultured in the presence of crude 1L-2 or recombinant IL-2. IL-2-dependent T  cell 
lines were relatively easily established from ATL patients but not from HTLV-I- healthy 
donors. All the IL-2-dependent T  cell lines have been maintained for at least 8 mo. The 
surface phenotypes of the T cell lines were analyzed by using mouse monoclonal antibodies 
reactive with T cell antigens, as previously described (7). The intensity of the fluorescence 
was analyzed by flow cytometry using Ortho Spectrum III (Ortho Pharmaceutical Co., 
NJ). 
Results and Discussion 
Clonal Continuity between In Vitro Cell Lines and Leukemic Cells in a Chronic ATL 
Case.  HTLV-I  + T  cell lines were established from a 34-y-old man with chronic 
ATL. In contrast to many ATL cases with acute clinical courses, he manifested 
no deterioration of his general clinical state for 10 y, except for massive erythro- 
dermia  and  sustained  leukocytosis.  Southern  blot  hybridization  with  HTLV-I 
U3R probe showed a common band in two DNA of the leukemic T  cells obtained 
at an interval of 2 mo. The result indicated that the leukemic ceils were comprised 
of a  monoclonally expanded  HTLV-I-infected T  cell clone.  When  peripheral 
blood lympbocytes (PBL) of the patient were cultured in the presence of an IL- 
2-containing conditioned medium,  the cells proliferated promptly within a  day 
of culture, lL-2-dependent growth continued and a cell line was established. The 
cell  line,  ED-40515,  bearing  the  T4  marker,  has  been  maintained  for >1  y. 
Using recombinant IL-2, independent cultures were initiated 3 mo after the first 
trial,  and  two more T  cell lines  with  the T4  + phenotype were established and 
maintained  for  10  mo.  Surface phenotype of these three T  cell lines was  T3 +, 
T4  +, T8-,  T 11 +, and positive for Tac antigen,  which were identical to that of 
original leukemic cells. All the cell lines remained dependent on IL-2.  Because 
of the peripheral T  cell property of the leukemic cells and the established T  cell 
lines of ATL, we analyzed the rearrangement profiles of the T# gene. Rearrange- 
ments of T~ gene were clearly shown by a decrease in intensities of the germline 
bands  (Eco  RI,  10.5  kb;  Barn  HI,  23  kb;  as  shown  in  Fig.  1C),  and  by  the 
appearance  of one  or  two  new  bands.  There  was  an  identical  rearrangement 
pattern  of the  T~ gene among all  of the  IL-2-dependent  T  cell  lines  and  the 
original leukemic cells (Fig.  1A).  In the DNA of original leukemic cells and the 
three established  T  cell lines,  the  10.5  kb  Eco RI  fragment of germline disap- 
peared, while a  rearranged 7 kb fragment appeared.  In Barn HI digests, the 23 
kb  germline  fragment  was  lost,  and  two  rearranged  fragments  of smaller size MAEDA  ET  AL.  BRIEF  DEFINITIVE  REPORT  2171 
FIGURE  1.  Clonality analysis of chronic ATL leukemic cells and T  cell lines derived from 
them by Southern blot hybridization using Ta probe and HTLV U3R probe. (A) Analysis of 
T  cell receptor gene rearrangement by T0 probe. Restriction enzymes used were: a, Eco RI; 
b, Barn  HI. (B) Analysis of HTLV integration site by HTLV U3R probe. DNA were digested 
with restriction enzyme Eco RI. Origin of DNA were: lane  1, human placenta;  2,  PBL of a 
chronic ATL patient T. Ya.; 3-6, cell lines derived from patient T. Ya.  [3,  ED°40515, 2 mo 
in culture; 4,  ED-40515,  4  mo in culture; 5,  ED-40810(S); 6,  ED-40810 (T)].  (C) Schematic 
demonstration of T  cell receptor gene rearrangement determined by To probe. 
appeared, indicating the rearrangement on both chromosomes. Coincidence of 
the  genotype  between  the  T  cell  lines  and  the  original  leukemic  cells  was 
confirmed by Southern blot hybridization with  HTLV  U3R  probe  (Fig.  1B). 
There was a band of the same size as that of original leukemic cells in all of three 
lines, and an additional band in ED-40515 cell DNA. The results strongly indicate 
that the three independently established T cell lines were derived from the major 
clone in the original leukemic cells,  which had monoclonally expanded in vivo. 
Established T Cell Lines Represent Clones that Differ from Major Leukemic Clones 
in Acute ATL.  We also established IL-2-dependent T  cell lines from PBL of five 
acute ATL patients. Four T  cell lines had a helper surface phenotype (T4+T8  -) 
consistent with  that of the  original  leukemic cells  of ATL.  However,  in  one 
patient, the established cell line had a phenotype of killer/suppressor, although 
original leukemic cells carried the T4+T8 -  phenotype. As was the case with the 
chronic ATL case, one or two rearranged fragments of the T~ gene was detected 
in each T  cell line, as well as the leukemic cells of these acute ATE cases  (Fig. 
2A).  When the profiles of the T~ gene rearrangement are compared between 
the cell line and the original leukemic cells, it is evident that the patterns of the 
Te gene rearrangement were different between pairs of the cell  line and the 
original leukemic cells (ATL-2, ATL-7, and ATL-12) (Fig. 2A).  Moreover, the 
HTLV genome was integrated in multiple copies in all these cell lines, as shown 2172  MAEDA  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIGURE  2.  Clonality analysis of ATL-derived T cell line cells and its original ATL leukemic 
cells. (A) T cell receptor gene rearrangement by T~ probe. DNA were digested with restriction 
enzymes: a, Eco RI; b, Barn HI. (B) HTLV integration site by HTLV U3R probe. Origin of 
DNA were: lane 1, human placenta; 2, PBL of patient T. Y.; 3, ATL-2 cell line derived from 
patient T. Y. (4 mo in culture); 4, ATL-2 cell line (6 mo in culture); 5, PBL of patient R. T.; 
6, ATL-7 cell line derived from patient R. T.; 7, PBL of patient K. N.; 8, ATL-12 cell line 
derived from patient K. N. 
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FIGURE 3.  The effect of IL-2 on the DNA synthesis by ATL leukemic cells. 5 x  10  4 Ficoll- 
Hypaque-separated peripheral blood mononuclear cells were cultured in a culture medium 
for 72 h in the presence of different concentration of purified IL-2. Cells were pulsed with 
methyl-[~H]tbymidine ([SH]TdR)  (2 Ci/mM) for the last 4 h, and the cells were harvested on 
glass  filter paper using cell harvester (Bellco  Glass  Co.,  Vineland,  NJ) and  [3H]thymidine 
incorporation was counted by Packard Mark II scintillation counter. (0) PBL from a chronic 
ATL patient T.  Ya. (O) and (A) PBL from two typical ATL patients, Peripheral blood cell 
count of the three patients were 23,000, 70,000 and 127,500 cells/ml, respectively. 
in  Fig.  2B.  The  patterns  of HTLV-I  provirus  integration  also  differ  between 
each pair of the leukemia cells and T  cell line, in agreement  with the difference 
in the T  cell receptor  gene rearrangement.  These  results demonstrate  unequiv- 
ocally that there is no clonal continuity between the leukemic cells of three acute 
ATL  patients  and  the  corresponding  established  HTLV-I +  IL-2-dependent  T 
cell lines. 
IL-2-Reactive and  -Nonreactive  Leukemic  Cells  in ATL  Cases.  As  expected,  a 
prompt  proliferative response  to IL-2 was observed in  the leukemic cells of this 
chronic  ATL  patient  (Fig.  3).  In  contrast,  IL-2  failed  to  induce  a  detectable 
proliferative response  in  leukemic  cells  freshly  isolated  from  the  typical  ATL MAEDA ET  AL.  BRIEF  DEFINITIVE REPORT  2173 
patients (Fig.  3).  Probably because of this unresponsiveness to  IL-2, leukemic 
cells of the majority of acute ATL cases did not grow in vitro (12).  Moreover, 
the lack of clonal continuity between the cell lines established from the patients 
with acute ATL, as evidenced by the data accumulated in this report, indicates 
that most established acute ATL cell lines do not represent the vast majority of 
leukemic cell clones expanded in vivo. Consequently, the acute ATL cell lines 
examined thus far may have been selected for survival and growth in vitro from 
the IL-2-reactive T  cells, which might have been infected with HTLV-I either 
in vivo or during in vitro culture (20).  Although the role of the IL-2 receptor 
system in HTLV-I-induced leukemogenesis remains ill-defined, apparently ATL 
cells differ markedly from normal T  cells,  which only express  IL-2 receptors 
transiently upon  T  cell  antigen receptor activation. Our  results on  the  IL-2- 
responsive chronic ATL case may indicate that there is an IL-2-reactive stage in 
HTLV-1  leukemogenic process.  Further studies on the IL-2 receptor on ATL 
cells and  the accumulation of similar  IL-2-reactive ATL cases  is  required  to 
clarify this possibility. 
Summary 
Using  the  clone-specific rearrangement of the  T  cell  receptor  gene as  the 
genetic marker of the clonotype, we analyzed the clonal origin of the interleukin 
2  (IL-2)-dependent human T-lymphotrophic virus I  (HTLV-I)-positive T  cell 
lines established  from various adult T  cell  leukemia (ATL) patients.  From a 
patient with chronic ATL, whose leukemic cells proliferated in vitro in response 
to  IL-2,  we  repeatedly  established  leukemic  T  cell  clones  having  the  same 
rearrangement profile of the Ta chain gene as the leukemic cells.  By contrast, 
established  cell  lines  from  acute  ATL  patients  had  different  /3  chain  gene 
rearrangements from those of the leukemic cells.  These HTLV-I  + T  cell lines 
might not be the direct progeny of the leukemic cells, but that of T  cells infected 
either in vivo or in vitro. These IL-2-reactive nonleukemic T  ceils  might have 
been  selected in vitro, because their leukemic cells failed to respond to  IL-2, 
despite the expression of IL-2 receptor. The analysis of the T  cell receptor gene 
rearrangement may give a  new approach for the elucidation of the mechanism 
of leukemogenesis and the origin of the HTLV-I  + T  cell lines in ATL. 
We thank M. Sato, K. Usami, K. Nasu, and K. Kita for providing sample materials, and 
M. Tsudo, Y. Wano,  M. Okada, and S.  Namiuchi and Kansai-Igaku-Kensa Center for 
excellent technical help. We also thank K. A. Smith for helpful advice, and H. Nakazato 
at  Suntory Biomedical  Research  Institute and  Takeda  Pharmaceutical  Co.,  Ltd.  for 
providing IL-2. 
Received  for publication 8July 1985 and in revised  form 6 September 1985. 
References 
1.  Yodoi, J., K. Takatsuki, and T. Masuda. 1974. Two cases of T-cell chronic leukemia 
in Japan. N. Engl. J. Med. 290:572. 
2.  Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki,  and H. Uchino.  1977. Adult T- 
cell leukemia: clinical and hematologic features of 16 cases. Blood. 50:48 I. 
3.  Poiesz, B.J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn,J. D. Minna, and R. C. Gallo. 
1980. Detection and isolation of type C retrovirus particles from fresh and cultured 2174  MAEDA ET  AL.  BRIEF  DEFINITIVE  REPORT 
lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad.  Sci. USA. 
77:7415. 
4.  Hinuma, Y.,  K.  Nagata, M.  Hanaoka, M.  Nakai, T.  Matsumoto, K.-I.  Kinoshita,  S. 
Shirakawa, and I. Miyoshi.  1981. Adult T-cell leukemia: Antigen in an ATL cell line 
and detection of antibodies to the antigen in human sera.  Proc. Natl. Acad.  Sci. USA. 
78:6476. 
5.  Yoshida,  M.,  I.  Miyoshi,  and  Y.  Hinuma.  1982.  Isolation and characterization of 
retrovirus from cell lines of human adult T-cell leukemia and its implication in the 
disease.  Proc. Natl. Acad.  Sci. USA.  79:2031. 
6.  Uchiyama, T., S. Broder, and T. A. Waldmann. 1981. A monoclonai antibody (anti- 
Tac) reactive with activated and functionally mature T  cells. I. Production of anti- 
Tac monoclonal antibody and distribution of Tac  ÷ cells. J. Immunol.  126:1393. 
7.  Tsudo, M.,  T.  Uchiyama, H.  Uchino, and J. Yodoi.  1983.  Failure of regulation of 
Tac antigen/TCGF receptor on adult T  cell leukemia cells by anti-Tac monoclonal 
antibody. Blood.  61 : 1014. 
8.  Yodoi, J., T. Uchiyama, and M. Maeda.  1983. T-cell growth factor receptor in adult 
T-cell leukemia. Blood.  62:509. 
9.  Yodoi, J.,  M. Okada, Y. Tagaya, K. Teshigawara, K. Fukui, N. Ishida, K. Ikuta, M. 
Maeda, T. Honjo, H. Osawa, T. Diamanstein, M. Tateno, and T. Yoshiki.  1985.  Rat 
lymphoid cell lines producing human T cell leukemia virus. II. Constitutive expression 
of rat interleukin 2 receptor.J. Exp. Med.  161:924. 
10.  Leonard, W. J., J. M. Depper, G. R. Crabtree, S. Rudikoff, J. Pumphrey, R.J. Robb, 
M.  Kronke, P. B. Svetlik,  N.J. Peffer, T. A. Waldmann, and W. C. Greene.  1984. 
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. 
Nature (Lond.). 311:626. 
11.  Nikaido, T., A. Shimizu, N. Ishida, H. Sabe,  K. Teshigawara, M.  Maeda, T.  Uchi- 
yama, J. Yodoi, and T.  Honjo.  1984.  Molecular cloning of cDNA encoding human 
interleukin-2 receptor. Nature (Lond.). 311:631. 
12.  Uchiyama, T., T. Hori, M. Tsudo, Y. Wano, H. Umadome, S. Tamori, J. Yodoi, M. 
Maeda,  H.  Sawami,  and  H.  Uchino.  1985.  Interleukin-2  receptor  (Tac  antigen) 
expressed on adult T  cell leukemia cells. J. Clin. Invest.  76:446. 
13.  Siu, G., S. P. Clark, Y. Yoshikai,  M. Malissen,  Y. Yanagi,  E. Straus, T. W. Mak, and 
L. Hood. 1984. The human T cell antigen receptor is encoded by variable, diversity, 
and joining  gene  segments  that  rearrange  to  generate  a  complete  V  gene.  Cell. 
37:393. 
14.  Hedrick,  S.,  D. Cohen,  E.  Nielsen,  and M.  Davis.  1984.  Isolation of cDNA clones 
encoding T-cell specific membrane-associated proteins. Nature (Lond.).  308:149. 
15.  Smith, K. A. 1980. T  cell growth factor. Immunol. Rev.  51:337. 
16.  Smith,  K. A., and D. A. Cantrell.  1985.  Interleukin  2 regulates its own receptors. 
Proc. Natl. Acad. Sci. USA.  82:864. 
17.  Ikuta,  K.,  T.  Ogura, A.  Shimizu,  and T.  Honjo.  1985.  Low frequency of somatic 
mutation in T cell antigen receptor/3 chain gene. Proc. Natl. Acad.  Sci. USA. In press. 
18.  Seiki,  M.,  S.  Hattori,  Y.  Hirayama,  and  M.  Yoshida.  1983.  Human  adult  T  cell 
leukemia virus: complete nucleotide sequence of the provirus genome integrated in 
leukemic cell DNA. Proc. Natl. Acad.  Sci. USA.  80:3618. 
19.  Yaoita,  Y.,  and  T.  Honjo.  1980.  Deletion  of immunoglobulin heavy chain  genes 
accompanies the class switch rearrangement. Biomed. Res.  1:164. 
20.  Hahn,  B.,  R.  C.  Gallo,  G.  Franchini,  M.  Popovic, T. Aoki, S.  Z. Salahuddin,  P.  D. 
Markham,  and  F.  Wong-Staal.  1984.  Clonal  selection  of human  T-cell  leukemia 
virus-infected cells in vivo and in vitro. Mol.  Biol. Med.  2:29. 